Prenetics Group Limited (PRE): Price and Financial Metrics
PRE Price/Volume Stats
Current price | $8.11 | 52-week high | $11.99 |
Prev. close | $8.05 | 52-week low | $3.09 |
Day low | $7.91 | Volume | 16,586 |
Day high | $8.30 | Avg. volume | 28,634 |
50-day MA | $7.74 | Dividend yield | N/A |
200-day MA | $5.54 | Market Cap | 98.98M |
PRE Stock Price Chart Interactive Chart >
Prenetics Group Limited (PRE) Company Bio
Prenetics Group Limited operates as a diagnostics and genetic testing company worldwide. It develops consumer genetic testing and early colorectal cancer screening products; and provides COVID-19 testing, rapid point of care and at-home diagnostic testing, and medical genetic testing products. The company's products include CircleDNA, a consumer genetic testing offering that uses whole exome sequencing; Project Screen, a COVID-19 test; and Circle HealthPod, a molecular testing product for COVID-19. It is also developing ColoClear, a non-invasive stool-based FIT-DNA test for colorectal cancer screening; Circle SnapShot, an at-home blood test with a user-friendly blood sample collection and result delivery system; Circle Medical, a test to identify causal genetic mutations for patients; and Circle One and F1x/Fem, a DNA profile and questionnaire based personalized nutrition solution. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRE Price Returns
1-mo | 15.69% |
3-mo | 104.37% |
6-mo | 36.76% |
1-year | 31.44% |
3-year | -86.38% |
5-year | N/A |
YTD | 39.83% |
2024 | -1.86% |
2023 | -80.30% |
2022 | N/A |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...